Check out Markus Siegelin's fundraising page - give.abta.org/fundraiser/467…

Targeting cellular respiration as a therapeutic strategy in glioblastoma pubmed.ncbi.nlm.nih.gov/37141415/

NEW #PaperoftheDay: "Targeting cellular respiration as a therapeutic strategy in glioblastoma" doi.org/10.18632/oncot… #cancerresearch #oncology #openaccess #peerreviewed #medEd #OA

We are excited to announce our recent publication in JCI insight entitled "OGDH and Bcl-xL loss causes synthetic lethality in glioblastoma". insight.jci.org/articles/view/… Thanks to all collaborators, reviewers and editors who helped to improve the manuscript!

Suppressing PD-L1 Expression via AURKA Kinase Inhibition Enhances Natural Killer Cell-Mediated Cytotoxicity against Glioblastoma mdpi.com/2860442 #mdpicells via Cells MDPI We are deeply grateful to everyone who contributed to this important work.

News: Eflornithine Improves Survival in Brain Cancer. bit.ly/3OsP10N

📢Highlights from SNO 2024 The SNO 2024 conference in Houston highlighted groundbreaking advancements in brain cancer research, with discussions on molecular diagnostics, novel treatments, and new collaborations in neuro-oncology. Ashley Love Sumrall, MD, FACP, FASCO SNO Keri Martinowich

Really impressive and critical work related to the field of metabolism and apoptosis.

Congrats to Columbia Neurosurgery’s Dr. Pavan Upadhyayula (PGY-4) for winning the NY Society of Neurosurgery's Resident Research Night! His work on ferroptosis and local drug delivery earned both the Grand Prize and People's Choice Award. A huge achievement!

The new Greenfield’s Neuropathology is finally out! Check out our chapter on adult-type gliomas. #pathology #neuropathology #PathTwitter

This is very interesting work in the field of cancer metabolism.

This brief video emphasizes the vital role of open-mindedness in cancer research. By adopting a broader perspective on cancer metabolism, we can facilitate breakthroughs for more effective interventions and a better understanding of the complexities in cancer biology.

I have been following your work for two decades and you have made seminal contributions to the field of cancer research, inspiring both myself and many others. Your expertise and experience make you a highly deserving candidate for the position of the next Director of the NCI.

This concept holds considerable relevance in the contemporary publishing landscape, especially given the substantial costs associated with publishing fees in the present era. Perhaps this could be considered for implementation in the NIH reform.

Wafik S. El-Deiry, MD, PhD, FACP Elon Musk Cancer research is a long-term investment in lives and innovation. Breakthroughs like anti-HER2 therapy for breast cancer and anti-Bcl-2 therapy for leukemia began in university labs and now save lives. Defunding the NCI risks losing the next breakthroughs in cancer research.

Charles Chostner Marboe, MD, 75, Esteemed Cardiovascular Pathologist and Beloved Columbia Educator pathology.columbia.edu/news/charles-c…